We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Two-Step PCR System Improves Quantification Sensitivity

By LabMedica International staff writers
Posted on 24 Aug 2010
A new two-step kit has been placed on the market for biotech researchers wishing to detect the activity of target genes expressed at low levels, even with hard-to-amplify samples.

The new Promega (Madison, WI, USA) GoTaq 2-Step RT-qPCR system comprises two Promega test modules: the GoScript Reverse Transcription System and the GoTaq qPCR Master Mix. More...


In the first step, by capitalizing on a carefully blended set of reagents the GoScript Reverse Transcriptase module directs highly efficient full-length complementary DNA (cDNA) synthesis from rare and abundant targets with up to five micrograms of RNA input. The transcription system improves the yield of cDNA even in the presence of common inhibitors such as ethanol.

In the second step, cDNA is quantified using the GoTaq qPCR Master Mix. Formulated with a hot-start DNA polymerase, the GoTaq qPCR Master Mix is optimized for reproducibly specific, sensitive, highly efficient qPCR using the standard or fast mode of a real-time PCR instrument. The GoTaq qPCR Master Mix module contains the green dye BRTY Green, which can fluoresce at twice brightness of the commonly used SYBR Green I dye.

The GoTaq 2-Step RT-qPCR System is a ready-to-use kit for analyzing a wide range of RNA targets by combining the high-activity of GoScript Reverse Transcription System with the ultrabright fluorescence of GoTaq qPCR Master Mix. The system is robust, requires little optimization, and is flexible for a variety of applications.

Related Links:
Promega






Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Gold Member
Platelet Function Analyzer
PL-12
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.